21/04/2026 22:11
|
Medical, Health & Aged Care
* Partnership enables timely access to botensilimab plus balstilimab through France’s government-reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named-patient programs (NPP)...